Exam – United Yam

Abortion pill complications are underreported, report finds

unitedyam September 24, 2025

Credit: Ivanko80/Shutterstock

CNA Staff, Sep 24, 2025 / 06:00 am (CNA).

Abortion pill complications go underreported in abortion industry studies and mainstream media, according to a recent report by the National Right to Life Committee (NRLC).

Abortion industry studies claim that serious complications are incredibly rare — occurring in less than half a percent of cases, according to the report “Missed, Misclassified, and Minimized: Why Abortion Pill Complications Are Underreported.”

But a study last year found that more than 1 in 10 women who took the abortion pill experienced serious complications such as hemorrhaging, infection, failed abortions, and surgical follow-up.

The author of the report, Randall O’Bannon, set out to investigate the discrepancy.

O’Bannon, director of education and research for the National Right to Life, found several factors contributing to the discrepancies. For one, he found that abortion providers often encourage women to conceal negative side effects and tell doctors they are symptoms of a miscarriage. O’Bannon also observed what he called a “contemptible lack of curiosity in the media” toward stories of women hurt by abortion drugs. Finally, serious complications are often categorized as “minor,” O’Bannon found.

O’Bannon said the “flawed or slanted industry studies” are “not good enough.”

“The public — and policymakers — deserve accurate, transparent reporting on the dangers of chemical abortion,” he said in a statement.

Dr. Ingrid Skop, vice president and director of medical affairs for Charlotte Lozier Institute and a board-certified OB-GYN, said she has encountered these medical complications in her own career as a medical provider.

“I have cared for dozens of women presenting to the ER with abortion drug complications, and they are told by abortion advocates there’s no need to report the use of abortion drugs,” she told CNA.

“When I see a woman in the ER with continued pain and bleeding sometimes weeks or even months after taking abortion drugs, she usually has retained pregnancy tissue and/or the dead baby, which the drugs have failed to expel,” Skop continued. “An unaware ER doctor is likely to give her more of the drugs that already failed rather than expediting the surgical aspiration she needs.”

“As a researcher and practicing OB-GYN, I can attest that the lived experience for many women reflects the data documented in this report,” Skop said.

“So where are all the women some of these later reports and studies say have been injured and abused by these drugs and their prescribers?” O’Bannon asked. “Once again, we see that they have been silenced and minimized, told their pain and blood and trauma are ‘minor complications’ that somehow just don’t rise to the level worthy of being noticed. But they suffer and bleed just the same.”

Looking at the numbers

Michael New, assistant professor of practice at the Busch School of Business for The Catholic University of America, noted that “the FDA’s own data shows that there are a number of health risks involved with chemical abortions.”

“Since the FDA approved the chemical abortion pill in 2000, the FDA’s own data indicates that there have been 32 deaths, 4,218 adverse events, 1,049 hospitalizations, 604 cases of blood loss requiring a transfusion, 418 infections, and 75 severe infections,” New, a senior associate scholar at the Charlotte Lozier Institute, told CNA.

The FDA figures “are underreported” due to a change in the reporting requirements implemented nearly a decade ago, according to New.

“In 2016, the FDA quit requiring that health care professionals report complications from chemical abortion drugs,” New said. “Since 2016, the reporting of complications has been voluntary.”

In 2020, during the COVID-19 pandemic, the FDA removed the requirement for women to have an in-person medical exam before being prescribed chemical abortion drugs.

Since then, “the number of complications has almost certainly increased,” New said.

Without a medical exam, abortion providers may unwittingly provide abortion drugs to women whose pregnancies are further along than is recommended for chemical abortions, as well as women who have ectopic pregnancies (a life-threatening condition where the embryo implants outside the uterus).

Trump administration continues to implement ‘unwise policy’

“The Biden administration FDA and thus far the Trump administration FDA have continued with this unwise policy,” New said.

Chemical abortions are sometimes falsely advertised as “safer than Tylenol.” But a chemical abortion is far less safe than even a surgical abortion, Skop noted.

“Complications occur at least four times as frequently following drug-induced abortions compared to surgical abortions, causing at least 1 in 15 women to require emergency care when the drugs are used as the FDA recommends,” Skop said. “Even more women suffer when they are taken at advanced gestational ages.”

“The abortion pill is being sold as safe, but independent data tell another story,” Carol Tobias, president of National Right to Life, said in a statement. “Women are being harmed, and the dangers are being ignored or hidden.”

“Abortion industry spin makes mifepristone abortions sound easy, but the truth is each abortion takes the life of a living preborn child and places the woman in danger,” Tobias said.

How can policymakers respond?

New noted that public officials could take several steps “to protect mothers and children” from these dangers, including requiring that “medical professionals report complications that arise from chemical abortions.”

In addition, the FDA “could require that women obtaining chemical abortions first have an in-person medical exam,” a change that New said the Trump administration could make “right away.”

“Thus far, it is disappointing that the Trump administration has not prioritized keeping women safe from unregulated chemical abortion drugs,” New said.

Skop added that “policymakers need better abortion data.”

“Extensive deficiencies affect abortion data collection in the U.S., including a lack of anonymized national reporting requirements,” Skop said.

“Women also need to know the true risk of abortion and potential complications, which are both physical and mental,” she continued.

Skop noted that “the majority of women with a history of abortion would have preferred to give birth if they had the necessary support.”

“Women also should know there are 2,750 pregnancy resource centers that want to walk alongside women facing an unintended pregnancy to provide any support they need,” Skop said.

Nonprofit organizations across the country exist to provide pregnant women and mothers with support — from baby clothes to ultrasounds to parenting classes.

“The abortion industry’s goal is to promote all-trimester abortion on demand,” Skop noted. “And lawmakers, the public, and most importantly, women considering abortion, must understand abortion advocates will mislead them to achieve that goal.”

Anti-assisted-suicide group says suicide laws expanding throughout U.S. in 2025

unitedyam September 19, 2025

null / Credit: nito/Shutterstock

Washington, D.C. Newsroom, Sep 19, 2025 / 14:31 pm (CNA).

This week the Patients Rights Action Fund, which works to “end the dangerous and discriminatory public policy of assisted suicide,” provided an update on current assisted suicide legislation in the United States, revealing the deadly practice’s ongoing expansion throughout the country.

In a Sept. 18 webinar, group coalitions director Jessica Rodgers explained that most states that allow assisted suicide follow the “Oregon model,” based on Oregan’s assisted suicide criteria.

The model requires “the patient to be 18 years of age or older, have a terminal illness with six months or less to live, make two or more separate requests with a 15-day waiting period in between, and have two witnesses, which can include heirs to the estate or friends of heirs,” Rodgers said.

“The drugs must be self-administered and all states do require the falsification of the death certificate,” Rodgers said, meaning the states list the underlying condition that qualifies the patient as the cause of death rather than the prescribed drug that ends his or her life.

States attempting expansions to assisted suicide laws

In 2025, new legislation was proposed in a number of states where assisted suicide is legal to advance its polices and limit some of the “safeguards” in place.

A New Jersey bill was proposed that would remove the 15-day waiting period and the second request if the prescriber thinks death will occur within the time period. The bill is still in play and has not been passed yet.

In Maine, a 15-day waiting period was reduced to seven days in cases when it is “in the best interests of the patient” according to the judgment of the prescriber. The legislation was passed and signed by the governor after the original version was amended that would have allowed the whole waiting period to be waived.

A Delaware bill passed that allows for advanced practice nurses to prescribe the medication that kills the patients. The bill has no requirements for an in-person exam or a mental health evaluation.

California proposed a major change that reduced the 15-day waiting period for assisted suicide to only 48 hours. The bill also removes the sunset date, which will keep the End of Life Option Act from expiring. The bill passed last week and is awaiting a signature by the governor.

Some states proposed expansions, but the legislation did not advance. In Washington, D.C., there was a public hearing on a bill that would remove the waiting period in certain cases, but no action was taken.

An Oregon bill was also not advanced that proposed nurse practitioners and physician assistants could prescribe to patients seeking assisted suicide. It also pushed for the waiting period to be reduced from 15 days to 48 hours and would waive the period completely if death is “expected imminently.”

Proposed legislation to legalize assisted suicide

Assisted suicide is legal in 10 states and D.C., but a number of other states have active legislation to legalize it.

In New York a bill to legalize assisted suicide was approved and is awaiting signature by the governor, which she must sign by the end of the year. The bill does not require the patient to be a resident of the state, has no waiting period, and does not require an in-person exam or a mental health evaluation.

In Rhode Island assisting a suicide is a felony, but there is proposed legislation to legalize assisted suicide that would require an in-person evaluation. The bill requires a 15-day waiting period between requests and an additional 48-hour waiting period that begins after the patient submits his or her signed request for the medication.

Nevada does not authorize assisted suicide, but legislation pushing for it proposed advanced practice nurses to be allowed to prescribe the drugs, no in-person exam requirement, only one witness necessarily, and no requirement for the patient to be a resident of the state.

The Nevada legislation does detail that the prescribed drugs would be the cause of death on the certificate rather than the underlying condition.

Legislation in Maryland would not require a mental health evaluation and has a broad meaning for “terminal illness” that can include treatable conditions. The bill has provisions that allow a patient to communicate through someone else “familiar with the individual’s manner of communicating.”

Proposed legislation in Massachusetts also has a broad definition for “terminal illness” that can include treatable conditions. There was a public hearing in Massachusetts in the state Joint Public Health Committee, which then moved the bill to a second committee on the state House side where it is still active.

In New Hampshire, a bill is pushing for no residency requirement, no in-person examination requirement, a broad “terminal illness” definition, and no mental health evaluation. The legislation also proposed a 48-hour waiting period and would allow for advanced practice nurses and physician assistants to prescribe the drugs.

A Tennessee House bill pushing the legalization of assisted suicide primarily follows the Oregon model. It does have a broad meaning for “terminal illness” that can include treatable conditions. On March 4, the first committee hearing was held on the matter, but it was rejected.

In Illinois, a 2025 bill to legalize assisted suicide in the state stalled and will cross over to the 2026 session. The bill had a five-day waiting period, no requirement for mental health evaluation, and broad terminal diagnosis language.

As legislation continues to be proposed and advances in assisted suicide expand, Patients Rights Action Fund highlighted the lack of mental health evaluations across states and noted that waiting periods are being quickly reduced after the initial passing of legislation.

“Ultimately, assisted suicide laws are inherently discriminatory,” Rodgers said on Sept. 18.

“They take a segment of our neighbors and say: ‘You get a lower standard of care than everybody else,’” she said. “The patients that qualify for assisted suicide are already inherently in a more vulnerable state because of their diagnosis and because of the financial costs that they’re facing with health care and the cost of treatment.”